HIGH GLUCOSE ELEVATES C-FOS AND C-JUN TRANSCRIPTS AND PROTEINS IN MESANGIAL CELL-CULTURES

被引:114
作者
KREISBERG, JI [1 ]
RADNIK, RA [1 ]
AYO, SH [1 ]
GARONI, JA [1 ]
SAIKUMAR, P [1 ]
机构
[1] AUDIE L MURPHY MEM VET ADM MED CTR, SAN ANTONIO, TX 78284 USA
关键词
D O I
10.1038/ki.1994.249
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
It has been previously shown that rat glomerular mesangial cells synthesized increased amounts of fibronectin, laminin, and type IV collagen when grown in medium containing 30 mM glucose. High glucose exerted its effect at the mRNA level since transcripts for all three extracellular matrix (ECM) proteins were similarly elevated. High glucose appeared to exert its effect on ECM mRNA levels through protein kinase C activation. Using quantitative reverse transcription (RT) PCR, we now report that mRNA levels for c-fos and c-Jun were increased approximately twofold after treatment with high glucose. The fos levels were elevated 15 minutes after addition of high glucose and were maintained elevated through 30 minutes; by one hour mRNA levels for fos returned to control levels, c-jun, on the other hand, was increased at two hours and remained elevated at 24 and 48 hours. Fibronectin mRNA levels were increased three- to fourfold at 24 and 48 hours. Immunofluorescence studies with polyclonal antibodies to c-fos and c-jun revealed that high glucose treatment for four hours increased nuclear staining intensity two- to threefold for both proteins. Nuclear staining for fos returned to control levels by 24 hours while staining for jun remained elevated. These determinations were made on images obtained on a confocal laser scanning microscope. Thus, high glucose may effect gene expression of ECM proteins by elevating the transcription factors c-fos and c-jun which complex with one another to form activator protein 1 (AP-1).
引用
收藏
页码:105 / 112
页数:8
相关论文
共 28 条
  • [21] STRUCTURAL-FUNCTIONAL RELATIONSHIPS IN DIABETIC NEPHROPATHY
    MAUER, SM
    STEFFES, MW
    ELLIS, EN
    SUTHERLAND, DER
    BROWN, DM
    GOETZ, FC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (04) : 1143 - 1155
  • [22] CHARACTERIZATION OF A NOVEL PROMOTER STRUCTURE AND ITS TRANSCRIPTIONAL REGULATION OF THE MURINE LAMININ-B1 GENE
    OKANO, R
    MITA, T
    MATSUI, T
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1132 (01) : 49 - 57
  • [23] FOS-ASSOCIATED PROTEIN-P39 IS THE PRODUCT OF THE JUN PROTO-ONCOGENE
    RAUSCHER, FJ
    COHEN, DR
    CURRAN, T
    BOS, TJ
    VOGT, PK
    BOHMANN, D
    TJIAN, R
    FRANZA, BR
    [J]. SCIENCE, 1988, 240 (4855) : 1010 - 1016
  • [24] DNA SEQUENCING WITH CHAIN-TERMINATING INHIBITORS
    SANGER, F
    NICKLEN, S
    COULSON, AR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) : 5463 - 5467
  • [25] FOS-ASSOCIATED CELLULAR P39 IS RELATED TO NUCLEAR TRANSCRIPTION FACTOR-AP-1
    SASSONECORSI, P
    LAMPH, WW
    KAMPS, M
    VERMA, IM
    [J]. CELL, 1988, 54 (04) : 553 - 560
  • [26] REQUIREMENT FOR FOS GENE-EXPRESSION IN THE TRANSCRIPTIONAL ACTIVATION OF COLLAGENASE BY OTHER ONCOGENES AND PHORBOL ESTERS
    SCHONTHAL, A
    HERRLICH, P
    RAHMSDORF, HJ
    PONTA, H
    [J]. CELL, 1988, 54 (03) : 325 - 334
  • [27] THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS
    SHAMOON, H
    DUFFY, H
    FLEISCHER, N
    ENGEL, S
    SAENGER, P
    STRELZYN, M
    LITWAK, M
    WYLIEROSETT, J
    FARKASH, A
    GEIGER, D
    ENGEL, H
    FLEISCHMAN, J
    POMPI, D
    GINSBERG, N
    GLOVER, M
    BRISMAN, M
    WALKER, E
    THOMASHUNIS, A
    GONZALEZ, J
    GENUTH, S
    BROWN, E
    DAHMS, W
    PUGSLEY, P
    MAYER, L
    KERR, D
    LANDAU, B
    SINGERMAN, L
    RICE, T
    NOVAK, M
    SMITHBREWER, S
    MCCONNELL, J
    DROTAR, D
    WOODS, D
    KATIRGI, B
    LITVENE, M
    BROWN, C
    LUSK, M
    CAMPBELL, R
    LACKAYE, M
    RICHARDSON, M
    LEVY, B
    CHANG, S
    HEINHEINEMANN, M
    BARRON, S
    ASTOR, L
    LEBECK, D
    BRILLON, D
    DIAMOND, B
    VASILASDWOSKIN, A
    LAURENZI, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) : 977 - 986
  • [28] SHANKLAND SI, 1993, J AM SOC NEPHROL, V4, pA802